What remains unknown about salvage and HDC therapy for Hodgkin lymphoma (Hodgkin disease)?

Updated: Sep 12, 2018
  • Author: Bradley W Lash, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Many questions relating to salvage and HDC therapy for patients with Hodgkin lymphoma need to be addressed and are the subject of ongoing clinical trials. These include the following:

  • The optimal salvage regimen or regimens

  • The ideal conditioning regimen or regimens

  • The potential benefits of twin transplants compared with single transplants

  • How to prospectively identify those patients who are unlikely to benefit from HDC and how to best manage their disease

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!